Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome

Peter G. McGovern, Richard S. Legro, Evan R. Myers, Huiman X. Barnhart, Sandra A. Carson, Michael P. Diamond, Bruce R. Carr, William D. Schlaff, Christos Coutifaris, Michael P. Steinkampf, John E. Nestler, Gabey Gosman, Phyllis C. Leppert, Linda C. Giudice

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.

Original languageEnglish (US)
Pages (from-to)442-444
Number of pages3
JournalFertility and sterility
Volume87
Issue number2
DOIs
StatePublished - Feb 1 2007

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome'. Together they form a unique fingerprint.

  • Cite this

    McGovern, P. G., Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., Steinkampf, M. P., Nestler, J. E., Gosman, G., Leppert, P. C., & Giudice, L. C. (2007). Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. Fertility and sterility, 87(2), 442-444. https://doi.org/10.1016/j.fertnstert.2006.06.050